Bernadette Hilgarth

Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response

Antonia Lopez‐Girona, Daniel Heintel, Ling‐Hua Zhang et al. · British Journal of Haematology · 2011 · 179 citations · Full text

Medicine, Oncology, Pharmacology +17

Overexpression of G protein‐coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma

Johanna Atamaniuk, Edit Porpaczy, Birgit Kainz et al. · European Journal of Clinical Investigation · 2012 · 127 citations · Full text

Life Sciences, Molecular Biology, Oncology +8

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Bernd Boidol, Christoph Kornauth, Emiel van der Kouwe et al. · Blood · 2017 · 72 citations

Medicine, Hematology, Oncology +13

Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.

Klaus Laczika, Matthew D. Novak, Bernadette Hilgarth et al. · Journal of Clinical Oncology · 1998 · 57 citations

Medicine, Hematology, Oncology +17

High Concordance of Karyotype Analysis and RT-PCR for CBF beta/MYH11 in Unselected Patients With Acute Myeloid Leukemia

Margit Mitterbauer, Klaus Laczika, Matthew D. Novak et al. · American Journal of Clinical Pathology · 2000 · 35 citations · Full text

Life Sciences, Genetics, Hematology +14